Physician profile
Daniel D Cerutti
NPI 1649368713
$6,119.08
in general payments reported to CMS, 2019-2025
19 companies · $529 in 2025
The $529 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,630 · 2020: $545 · 2021: $657 · 2022: $1,288 · 2023: $792 · 2024: $679 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,999.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,397.41 | 2022-2025 | Infuse, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,167.44 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $650.07 | 2019-2025 | Acuvue |
| Allergan, INC. | $329.62 | 2019-2020 | |
| Glaukos Corporation | $298.78 | 2022 | |
| Lkc Technologies, INC. | $280.79 | 2024-2025 | |
| Alcon Vision LLC | $230.99 | 2019 | |
| Coopervision INC. | $226.69 | 2019-2024 | Misight Contact Lens |
| Mallinckrodt Hospital Products INC. | $224.11 | 2021-2023 | Acthar |
| Sun Pharmaceutical Industries INC. | $214.51 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $192.37 | 2019 | |
| Biotissue Holdings INC. | $144.07 | 2023 | |
| Oyster Point Pharma, INC. | $122.78 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $122.60 | 2019 | |
| Novartis Pharmaceuticals Corporation | $120.94 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $120.67 | 2019 | |
| Kala Pharmaceuticals, INC. | $115.67 | 2021 | |
| Abbvie INC. | $107.84 | 2023 | Durysta |
| Abb Con-Cise Optical Group LLC | $51.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cerutti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.